Year To Quarter End Consolidated Statement Of Comprehensive Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7298417

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
5,252,000,000 JPY
5,757,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-3,623,000,000 JPY
3,991,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-180,000,000 JPY
-140,000,000 JPY
Other comprehensive income
-3,804,000,000 JPY
3,851,000,000 JPY
Comprehensive income
1,447,000,000 JPY
9,608,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,442,000,000 JPY
9,528,000,000 JPY
Comprehensive income attributable to non-controlling interests
5,000,000 JPY
80,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.